30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

curasan Gains CE Mark for Spinevisc Hyaluronic Acid -

curasan is launching Spinevisc® hyaluronic acid (HA) for the treatment of facet joint arthrosis. Spinevisc will allow the company to address new target customer groups such as neuroradiologists and interventional pain therapists, as well as spine surgeons. Other HA-based products from curasan include Curavisc for the treatment of arthritic joints ex-U.S. and CERASORB bone replacement material. (curasan AG, 10/1/19)